Semnur Pharmaceuticals, Inc. (SMNR)
0.45
-0.01
(-2.17%)
USD |
OTCM |
Sep 18, 16:00
Semnur Pharmaceuticals Cash from Operations (Quarterly) : -2.138M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.138M |
| March 31, 2026 | -2.67M |
| December 31, 2025 | -3.605M |
| September 30, 2025 | -2.078M |
| June 30, 2025 | 0.268M |
| March 31, 2025 | -0.399M |
| December 31, 2024 | -1.407M |
| September 30, 2024 | -2.995M |
| June 30, 2024 | -0.1145M |
| Date | Value |
|---|---|
| March 31, 2024 | -0.3742M |
| December 31, 2023 | -0.159M |
| September 30, 2023 | -0.0757M |
| June 30, 2023 | -0.1577M |
| March 31, 2023 | -0.2404M |
| December 31, 2022 | -0.1658M |
| September 30, 2022 | -0.0416M |
| June 30, 2022 | -0.2186M |
| March 31, 2022 | 0.00 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Scilex Holding Co. | -6.723M |
| ANI Pharmaceuticals, Inc. | 56.67M |
| Corcept Therapeutics, Inc. | 33.54M |
| Veru, Inc. | -5.467M |
| Johnson & Johnson | 8.616B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 2.074M |
| Free Cash Flow | -10.49M |
| Free Cash Flow Per Share (Quarterly) | -0.0093 |
| Free Cash Flow to Equity (Quarterly) | -5.507M |
| Free Cash Flow to Firm (Quarterly) | -2.015M |
| Free Cash Flow Yield | -10.45% |